XNK03

N/A

Report date: 2022/11/24 17:38:18

Base Information

Drug NameXNK03
Drug Alias NameXNK-03
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Transitional Cell
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXNK Therapeutics AB
China Registration ClassN/A

Develop Information

Active CompaniesXNK Therapeutics AB
Inactive CompaniesN/A
Active IndicationsCarcinoma, Transitional Cell
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A